{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:53:29Z","timestamp":1793224409628,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.molimm.2020.11.010","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T19:12:44Z","timestamp":1606504364000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["A novel BAFF antagonist, BAFF-Trap, effectively alleviates the disease progression of systemic lupus erythematosus in MRL\/lpr mice"],"prefix":"10.1016","volume":"129","author":[{"given":"Chaoheng","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2020.11.010_bib0005","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1749-6632.2009.04671.x","article-title":"Antitreponemal antibodies leading to autoantibody production and protection from atherosclerosis in Kitavans from Papua New Guinea","volume":"1173","author":"Agmon-Levin","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.molimm.2020.11.010_bib0010","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1136\/annrheumdis-2014-206016","article-title":"The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus","volume":"74","author":"Alexander","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molimm.2020.11.010_bib0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000431278","article-title":"Complement in lupus nephritis: new perspectives","volume":"1","author":"Bao","year":"2015","journal-title":"Kidney Dis."},{"key":"10.1016\/j.molimm.2020.11.010_bib0020","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/BOR.0000000000000201","article-title":"New insights into B cell biology in systemic lupus erythematosus and Sjogren\u2019s syndrome","volume":"27","author":"Bird","year":"2015","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.molimm.2020.11.010_bib0025","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/jnr.23612","article-title":"Temporal kinetics of macrophage polarization in the injured rat spinal cord","volume":"93","author":"Chen","year":"2015","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.molimm.2020.11.010_bib0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/TCRM.S19819","article-title":"New treatment options for lupus - a focus on belimumab","volume":"8","author":"Chiche","year":"2012","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.molimm.2020.11.010_bib0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.pathol.2017.01.003","article-title":"The role of interleukin-17A in the pathogenesis of kidney diseases","volume":"49","author":"Cortvrindt","year":"2017","journal-title":"Pathology"},{"key":"10.1016\/j.molimm.2020.11.010_bib0040","first-page":"247","article-title":"Advances in mechanisms of systemic lupus erythematosus","volume":"17","author":"Dema","year":"2014","journal-title":"Discov. Med."},{"key":"10.1016\/j.molimm.2020.11.010_bib0045","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1002\/art.27534","article-title":"Targeted tumor necrosis factor receptor I preligand assembly domain improves skin lesions in MRL\/lpr mice","volume":"62","author":"Deng","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2020.11.010_bib0050","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.biopha.2014.08.004","article-title":"Mononuclear cells phagocytic activity affects the crosstalk between immune and cancer cells","volume":"68","author":"Djaldetti","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.molimm.2020.11.010_bib0055","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.semarthrit.2016.10.005","article-title":"Unraveling the podocyte injury in lupus nephritis: clinical and experimental approaches","volume":"46","author":"Dos Santos","year":"2017","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.molimm.2020.11.010_bib0060","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood-2006-06-027755","article-title":"BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway","volume":"109","author":"Endo","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2020.11.010_bib0065","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12016-016-8551-x","article-title":"CD20-mimotope peptide active immunotherapy in systemic lupus erythematosus and a reappraisal of vaccination strategies in rheumatic diseases","volume":"52","author":"Favoino","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.molimm.2020.11.010_bib0070","first-page":"371","article-title":"Murine models of Sjogren\u2019s syndrome. Evolution of the lacrimal gland inflammatory lesions","volume":"32","author":"Jabs","year":"1991","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.molimm.2020.11.010_bib0075","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/ard.2007.075762","article-title":"Differential effects of epratuzumab on peripheral blood B cells of patients with systemic lupus erythematosus versus normal controls","volume":"67","author":"Jacobi","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molimm.2020.11.010_bib0080","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav1648","article-title":"Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus","volume":"11","author":"Kansal","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molimm.2020.11.010_bib0085","first-page":"32","article-title":"Changes of memory B- and T-cell subsets in lupus nephritis patients","volume":"54","author":"Kosalka","year":"2016","journal-title":"Folia Histochem. Cytobiol."},{"key":"10.1016\/j.molimm.2020.11.010_bib0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaut.2012.05.009","article-title":"The complexity of the BAFF TNF-family members: implications for autoimmunity","volume":"39","author":"Lahiri","year":"2012","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.molimm.2020.11.010_bib0095","first-page":"121","article-title":"Generation and characterization of tabalumab, a human monoclonal antibody that neutralizes both soluble and membrane-bound B-cell activating factor","volume":"7","author":"Manetta","year":"2014","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.molimm.2020.11.010_bib0100","first-page":"349","article-title":"[B lymphocyte stimulator in systemic lupus erythematosus]","volume":"50","author":"Mercado","year":"2012","journal-title":"Rev. Med. Inst. Mex. Seguro Soc."},{"key":"10.1016\/j.molimm.2020.11.010_bib0105","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/art.27233","article-title":"Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II\/III systemic lupus erythematosus evaluation of rituximab trial","volume":"62","author":"Merrill","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2020.11.010_bib0110","first-page":"CD009226","article-title":"Rituximab for thyroid-associated ophthalmopathy","author":"Minakaran","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.molimm.2020.11.010_bib0115","first-page":"1","article-title":"Biological and targeted therapies of systemic lupus erythematosus: evidence and the state of the art","author":"Mok","year":"2017","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.molimm.2020.11.010_bib0120","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.it.2017.02.001","article-title":"Expanding the B cell-centric view of systemic lupus erythematosus","volume":"38","author":"Morawski","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.molimm.2020.11.010_bib0125","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4049\/jimmunol.173.2.807","article-title":"B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells","volume":"173","author":"Ng","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2020.11.010_bib0130","first-page":"321","article-title":"Augmerosen, BCL-2 antisense oligonucleotide - Genta, G 3139, GC 3139, oblimersen sodium","volume":"8","author":"Oblimersen","year":"2007","journal-title":"Drugs R."},{"key":"10.1016\/j.molimm.2020.11.010_bib0135","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.autrev.2011.10.010","article-title":"Macrophages and neutrophils in SLE-An online molecular catalog","volume":"11","author":"Orme","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.molimm.2020.11.010_bib0140","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejca.2016.10.017","article-title":"Nuclear transportation of exogenous epidermal growth factor receptor and androgen receptor via extracellular vesicles","volume":"70","author":"Read","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.molimm.2020.11.010_bib0145","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/art.34359","article-title":"Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study","volume":"64","author":"Rovin","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2020.11.010_bib0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145788","article-title":"Modulation of cytokine secretion allows CD4 t cells secreting IL-10 and IL-17 to simultaneously participate in maintaining tolerance and immunity","volume":"10","author":"Saito","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2020.11.010_bib0155","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/0961203315608254","article-title":"Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus","volume":"25","author":"Salazar-Camarena","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.molimm.2020.11.010_bib0160","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/leu.2015.174","article-title":"The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells","volume":"30","author":"Saulep-Easton","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.molimm.2020.11.010_bib0165","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.intimp.2011.11.019","article-title":"Novel, orally active, proteasome inhibitor, delanzomib (CEP-18770), ameliorates disease symptoms and glomerulonephritis in two preclinical mouse models of SLE","volume":"12","author":"Seavey","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.molimm.2020.11.010_bib0170","article-title":"Recent thymic emigrants, T regulatory cells, and BAFF level in children with X-linked agammaglobulinaemia in association with chronic respiratory disease","author":"Sharapova","year":"2017","journal-title":"Allergol. Immunopathol. (Madr)"},{"key":"10.1016\/j.molimm.2020.11.010_bib0175","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/cbf.3169","article-title":"Binding of B-cell maturation antigen to B-cell activating factor induces survival of multiple myeloma cells by activating Akt and JNK signaling pathways","volume":"34","author":"Shen","year":"2016","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.molimm.2020.11.010_bib0180","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4049\/jimmunol.1501061","article-title":"The expression of BAFF is controlled by IRF transcription factors","volume":"196","author":"Sjostrand","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2020.11.010_bib0185","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1021\/pr0502525","article-title":"Systematic evaluation of sample preparation methods for gel-based human urinary proteomics: quantity, quality, and variability","volume":"5","author":"Thongboonkerd","year":"2006","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.molimm.2020.11.010_bib0190","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/clinchem\/38.6.860","article-title":"Preliminary treatment of urinary proteins improves electrophoretic analysis and immunodetection","volume":"38","author":"Verdier","year":"1992","journal-title":"Clin. Chem."},{"key":"10.1016\/j.molimm.2020.11.010_bib0195","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2249.2011.04460.x","article-title":"Translational Mini-Review Series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjogren\u2019s syndrome: clinical implications and effects of B cell-targeted therapies","volume":"167","author":"Vossenkamper","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2020.11.010_bib0200","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.intimp.2016.04.018","article-title":"The double-edge role of B cells in mediating antitumor T-cell immunity: pharmacological strategies for cancer immunotherapy","volume":"36","author":"Wang","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.molimm.2020.11.010_bib0205","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/jlb.66.3.391","article-title":"Modulation of macrophage and B cell function by glycosaminoglycans","volume":"66","author":"Wrenshall","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.molimm.2020.11.010_bib0210","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1365-2567.2012.03553.x","article-title":"Increased survival and reduced renal injury in MRL\/lpr mice treated with a human Fcgamma receptor II (CD32) peptide","volume":"136","author":"Xi","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.molimm.2020.11.010_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2017.04.013","article-title":"B cell-activating factor regulates the survival of B lymphocytes infected with human cytomegalovirus","volume":"187","author":"Xu","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.molimm.2020.11.010_bib0220","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1189\/jlb.1112562","article-title":"Regulatory B cells suppress imiquimod-induced, psoriasis-like skin inflammation","volume":"94","author":"Yanaba","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.molimm.2020.11.010_bib0225","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/intimm\/dxh259","article-title":"BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors","volume":"17","author":"Zhang","year":"2005","journal-title":"Int. Immunol."},{"key":"10.1016\/j.molimm.2020.11.010_bib0230","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/jcph.686","article-title":"Pharmacokinetics, Pharmacodynamics, Safety, and Clinical Activity of Multiple Doses of RCT-18 in Chinese Patients With Systemic Lupus Erythematosus","volume":"56","author":"Zhao","year":"2016","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.molimm.2020.11.010_bib0235","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41392-019-0051-z","article-title":"Therapeutic effects of a novel BAFF blocker on arthritis","volume":"4","author":"Zhou","year":"2019","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016158902030540X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016158902030540X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:35:49Z","timestamp":1758980149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016158902030540X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":47,"alternative-id":["S016158902030540X"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2020.11.010","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel BAFF antagonist, BAFF-Trap, effectively alleviates the disease progression of systemic lupus erythematosus in MRL\/lpr mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2020.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}